I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 5 studies | 40% ± 16% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 5% | |
| interneuron | 4 studies | 38% ± 17% | |
| glutamatergic neuron | 3 studies | 48% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 5 studies | 40% ± 16% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 5% | |
| interneuron | 4 studies | 38% ± 17% | |
| glutamatergic neuron | 3 studies | 48% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 37% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 94% | 1054.85 | 231 / 245 | 98% | 21.13 | 490 / 502 |
| breast | 97% | 1210.62 | 443 / 459 | 92% | 9.55 | 1028 / 1118 |
| brain | 92% | 2271.45 | 2425 / 2642 | 95% | 16.52 | 669 / 705 |
| thymus | 97% | 956.81 | 633 / 653 | 89% | 8.54 | 540 / 605 |
| lung | 95% | 1304.46 | 550 / 578 | 82% | 9.30 | 944 / 1155 |
| uterus | 90% | 877.85 | 153 / 170 | 76% | 9.34 | 348 / 459 |
| skin | 74% | 4232.50 | 1330 / 1809 | 87% | 11.01 | 409 / 472 |
| kidney | 67% | 521.82 | 60 / 89 | 76% | 15.62 | 683 / 901 |
| bladder | 71% | 716.00 | 15 / 21 | 66% | 6.83 | 332 / 504 |
| intestine | 70% | 557.02 | 675 / 966 | 62% | 4.99 | 327 / 527 |
| esophagus | 33% | 215.73 | 480 / 1445 | 76% | 10.67 | 139 / 183 |
| stomach | 31% | 218.81 | 112 / 359 | 72% | 5.60 | 207 / 286 |
| adrenal gland | 26% | 243.41 | 68 / 258 | 74% | 36.97 | 170 / 230 |
| blood vessel | 100% | 4302.07 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2010.42 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 5% | 42.37 | 16 / 328 | 91% | 10.31 | 162 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 10.77 | 35 / 45 |
| spleen | 69% | 501.41 | 166 / 241 | 0% | 0 | 0 / 0 |
| ovary | 23% | 186.02 | 41 / 180 | 45% | 2.91 | 194 / 430 |
| eye | 0% | 0 | 0 / 0 | 66% | 6.84 | 53 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 3.56 | 18 / 29 |
| liver | 7% | 41.48 | 15 / 226 | 48% | 3.85 | 194 / 406 |
| heart | 48% | 334.61 | 417 / 861 | 0% | 0 | 0 / 0 |
| muscle | 7% | 41.91 | 59 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.42 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048512 | Biological process | circadian behavior |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_0045202 | Cellular component | synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| Gene name | GPR176 |
| Protein name | G-protein coupled receptor 176 (HB-954) |
| Synonyms | |
| Description | FUNCTION: Orphan receptor involved in normal circadian rhythm behavior. Acts through the G-protein subclass G(z)-alpha and has an agonist-independent basal activity to repress cAMP production. . |
| Accessions | ENST00000543580.7 [Q14439-2] ENST00000299092.4 [Q14439-3] ENST00000561100.2 [Q14439-1] Q14439 |
